Jingu Kazuhiko, Sasagawa Kazushi, Kagaya Akiko, Ochiai Takenori
Dept. of Surgery, Satte General Hospital.
Gan To Kagaku Ryoho. 2005 Dec;32(13):2117-20.
We report herein a case with stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy. A 65-year-old female was diagnosed as having type 3 gastric cancer with para-aortic lymph node metastases. She underwent total gastrectomy with extended lymph node dissection on March 2003. Histopathological examination revealed that the tumor was poorly-differentiated adenocarcinoma with para-aortic lymph nodes metastases and completely resected. After the operation,she was treated by adjuvant chemotherapy with TS-1. In March of 2004, she suffered from hematuria, and a CT scan revealed para-aortic lymph nodes metastases and left kidney metastasis. Then, she was treated by a weekly infusion of paclitaxel as second-line chemotherapy. After 3 courses, the tumor disappeared and efficacy was judged as CR. Moreover, CR was maintained after 7 courses. At this writing in January of 2005, she is well and has been treated with paclitaxel without any severe adverse events. Therefore, weekly paclitaxel therapy was considered to be one of the promising second-line chemotherapies for advanced or recurrent gastric cancer previously treated by TS-1.
我们在此报告一例IV期胃癌患者,该患者先前接受替吉奥(TS-1)治疗,对每周一次的紫杉醇二线化疗完全缓解。一名65岁女性被诊断为3型胃癌伴主动脉旁淋巴结转移。2003年3月,她接受了全胃切除术及扩大淋巴结清扫术。组织病理学检查显示,肿瘤为低分化腺癌伴主动脉旁淋巴结转移,且已完全切除。术后,她接受了替吉奥辅助化疗。2004年3月,她出现血尿,CT扫描显示主动脉旁淋巴结转移及左肾转移。随后,她接受每周一次的紫杉醇静脉输注作为二线化疗。3个疗程后,肿瘤消失,疗效判定为完全缓解(CR)。而且,7个疗程后仍维持完全缓解状态。在撰写本文时的2005年1月,她情况良好,一直在接受紫杉醇治疗,未出现任何严重不良事件。因此,对于先前接受替吉奥治疗的晚期或复发性胃癌患者,每周一次的紫杉醇治疗被认为是一种有前景的二线化疗方案。